CLINICAL_TRIALS
trial_result
· 2020-03-09
Clinical Trial Update: Efficacy and Safety Study of I10E in Treatment of Patients With CIDP [Phase 3]
Summary
Phase 3 trial of I10E in chronic inflammatory demyelinating polyradiculoneuropathy completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Phase 3 | Status: COMPLETED | Results posted: 2020-03-09